CHEMI-PHARM AS - 10140819 | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

CHEMI-PHARM AS

Summary report

Date of report 12.03.2025

CHEMI-PHARM AS
10140819 - Registered
Founded in 16.04.1997
Fixed capital 25,600 €

VAT  
EE100310771 (start 01.05.1997)
start end
01.05.1997 -
E-invoicing recipient
Telema

Add CHEMI-PHARM AS data to your system

download JSON download CSV

Add CHEMI-PHARM AS data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

Don't have CRM? Read more

keywords

  • pesemisvahendite tootmine

CHEMI-PHARM AS

Scores and ratings

Reputation score

What is Reputation score?

Credit Score

Trustworthy 0.01

Loader

What is Credit Score?

Open the reports you want to print

Employees and salaries

CHEMI-PHARM AS

Number of employees and estimated average salaries
?

CHEMI-PHARM AS

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................
2015 I........................

Deciders and beneficiaries

CHEMI-PHARM AS

Decision-makers
?

Ruth Oltjer

Relations: 7
Turnover 2024: 16 164 368 €
Employees: 105
Ruth Oltjer
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 16970

Date of birth: ......

Active relations 7

Production of washing toolsActivities of business organizationsReal Estate RentalBusiness adviceLeisure Interest ClubActivities of management companiesWholesale trade of various goods

Reza Yeganeh Khonsari

Relations: 1
Turnover 2024: 12 501 133 €
Employees: 66
Reza Yeganeh Khonsari
★☆☆☆

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 9520

Date of birth: ......

Active relations 1

Production of washing tools
*Every member of the management board may represent the public limited company in concluding all transactions.

CHEMI-PHARM AS

History of right of representation
?
Field
Manufactoring
Business age
27y
Beneficial country:
Estonia
 
Ruth Oltjer ... - ...
1997
2001
2005
2009
2013
2017
2021
2025
1997
2000
2002
2005
2007
2010
2012
2015
2017
2020
2022
2025

CHEMI-PHARM AS

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
30%
0.01
..................
70%

Former owners

NameCredit ScorePaymentBeginningEnding
!
..................
0.01
..................
!
..................
0.01
..................
!
..................

CHEMI-PHARM AS

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
0.15
............
0.01
............
0.01
............
0.01
............
0.01
............
0.01
............
0.01
............
!
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnding
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
!
..................
!
..................

CHEMI-PHARM AS

Subsidiaries and associates
?

Former subsidiaries and associates

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
100%
0.01
..................
10%

Former subsidiaries and associates

NameCredit ScorePaymentBeginningEnding
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

CHEMI-PHARM AS

Goodwill

CHEMI-PHARM AS

Taxes paid and estimated average salaries

CHEMI-PHARM AS

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................
2015 IV* ............* ..............................
2015 III* ............* ..............................
2015 II* ............* ..............................
2015 I* ............* ..............................

CHEMI-PHARM AS

Sales revenue by business area

CHEMI-PHARM AS

Sales revenue by country

CHEMI-PHARM AS

Financial indicators and prognosis

CHEMI-PHARM AS

Financial raiting: "GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

CHEMI-PHARM AS

Real estate as of 12.03.2025

Active and unactive real estate

igon I......
igon V......
igon K......
igon P......
igon P......

CHEMI-PHARM AS

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 28.06.2024 ......
2022 01.01.2022–31.12.2022 30.06.2023 ......
2021 01.01.2021–31.12.2021 30.06.2022 ......
2020 01.01.2020–31.12.2020 03.06.2021 ......
2019 01.01.2019–31.12.2019 22.05.2020 ......
2018 01.01.2018–31.12.2018 15.05.2019 ......
2017 01.01.2017–31.12.2017 26.04.2018 ......
2016 01.01.2016–31.12.2016 04.05.2017 ......
2015 01.01.2015–31.12.2015 15.06.2016 ......
2014 01.01.2014–31.12.2014 25.06.2015 ......
2013 01.01.2013–31.12.2013 12.06.2014 ......
2012 01.01.2012–31.12.2012 29.05.2013 ......
2011 01.01.2011–31.12.2011 15.06.2012 ......
2010 01.01.2010–31.12.2010 15.06.2011 ......
2009 01.01.2009–31.12.2009 18.06.2010 ......
2008 01.01.2008–31.12.2008 29.06.2009 ......
2007 01.01.2007–31.12.2007 26.06.2008 ......
2006 01.01.2006–31.12.2006 28.06.2007 ......
2005 01.01.2005–31.12.2005 30.06.2006 ......
2004 01.01.2004–31.12.2004 21.06.2005 ......
2003 01.01.2003–31.12.2003 15.06.2004 ......
2002 01.01.2002–31.12.2002 30.06.2003 ......
2001 01.01.2001–31.12.2001 27.06.2002 ......
2000 01.01.2000–31.12.2000 26.06.2001 ......

Liabilities and debts

CHEMI-PHARM AS

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

CHEMI-PHARM AS

Reports and assets-liabilities overview 12.03.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

CHEMI-PHARM AS

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Private debt ...... €

Total debt claims: ...... €

Latest events
...... ......

CHEMI-PHARM AS

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......
2015 IV* ...... €...... €...... €...... €......
2015 III* ...... €...... €...... €...... €......
2015 II* ...... €...... €...... €...... €......
2015 I* ...... €...... €...... €...... €......

CHEMI-PHARM AS

Bailiff's enforcement proceedings as of 12.03.2025
?

Bailiff's enforcement proceedings MISSING

CHEMI-PHARM AS

Regulations of the Payment Order Department as of 12.03.2025
?

Regulations of the Payment Order Department MISSING

CHEMI-PHARM AS

Court orders in the register as of 12.03.2025
?
Logo

Puuduste kõrvaldamise määrus

26.09.2023

Regulation number: Ä 10012152 / M6

Regulation status has entered into force: 26.09.2023

Regulation status: Allkirjastatud

Logo

Puuduste kõrvaldamise määrus

22.11.2021

Regulation number: Ä 10012152 / M5

Regulation status has entered into force: 23.11.2021

Date of enforcement of order or additional period: 22.11.2021

Regulation status: Puudused kõrvaldatud

CHEMI-PHARM AS

Decisions of the Consumer Disputes Committee as of 12.03.2025
?

Consumer disputes MISSING

CHEMI-PHARM AS

Court hearings as of 12.03.2025
?

Court hearings MISSING

CHEMI-PHARM AS

Rulings as of 12.03.2025
?

Court settlemets MISSING

CHEMI-PHARM AS

Notices and announcements as of 12.03.2025
?
Logo

Notice of division of a company

01.06.2023
Äriühingu jagunemise teade
Avaldamise algus: 01.06.2023
Avaldamise lõpp: tähtajatu
Aktsiaselts CHEMI-PHARM (registrikood 10140819) avaldab teadaande äriseadustiku (ÄS) § 447 lõike 2¹ alusel.

Ühing teatab jagunemisest. Jagunemisel osalesid Aktsiaselts CHEMI-PHARM (registrikood 10140819) ja Osaühing Chemi-Pharm Group (registrikood: 10449072), asukoht: Serva 44a. Äriühingu jagunemise teade
Aktsiaselts CHEMI-PHARM (registrikood 10140819, aadress Tänassilma tee 11, Tänassilma küla, Saku vald, Harju maakond, e-posti aadress chemi-pharm@chemi-pharm.com, edaspidi nimetatud Ühing) avaldab teadaande äriseadustiku (ÄS) § 447 lõike 2¹ alusel ja teatab jagunemisest.
Jagunemisel osalesid Ühing ja Osaühing Chemi-Pharm Group (registrikood 10449072, aadress Serva tn 44a, Tallinn). Jagunemine toimus eraldumise teel, mille käigus Ühing andis osa oma varast üle omandavale ühingule Osaühingule Chemi-Pharm Group. Jagunemine kanti äriregistrisse 31.05.2023.
Kui jagunemisel osalevate ühingute võlausaldajad ei saa nõuda rahuldamist ja nad põhistavad, et jagunemine võib ohustada nende nõuete täitmist, siis on neil võimalus esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 447 lg 2¹) Ühingu ülaltoodud kontaktandmetel.
Aktsiaselts CHEMI-PHARM

Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 447 lg 21). Ruth@chemi-pharm.com

Aktsiaselts CHEMI-PHARM
Tänassilma küla, Saku vald, Harju maakond, Tänassilma tee 11
Telefon: +372 6778806
E-post: chemi-pharm@chemi-pharm.com
Teadaande number 2080493
Logo

Notice of division of a company

01.06.2023
Äriühingu jagunemise teade
Avaldamise algus: 01.06.2023
Avaldamise lõpp: tähtajatu
Osaühing Chemi-Pharm Group (registrikood 10449072) avaldab teadaande äriseadustiku (ÄS) § 447 lõike 2¹ alusel.

Ühing teatab jagunemisest. Jagunemisel osalesid Osaühing Chemi-Pharm Group (registrikood 10449072) ja Aktsiaselts CHEMI-PHARM (registrikood: 10140819), asukoht: Tänassilma tee 11, Saku. Äriühingu jagunemise teade
Osaühing Chemi-Pharm Group (registrikood 10449072, aadress Serva tn 44a, Tallinn; e-posti aadress: ruth@chemi-pharm.com; edaspidi nimetatud Ühing avaldab teadaande äriseadustiku (ÄS) § 447 lõike 2¹ alusel ja teatab jagunemisest.
Jagunemisel osalesid Ühing ja Aktsiaselts CHEMI-PHARM (registrikood 10140819, aadress Tänassilma tee 11, Tänassilma küla, Saku vald, Harju maakond, e-posti aadress chemi-pharm@chemi-pharm.com). Jagunemine toimus eraldumise teel, mille käigus Aktsiaselts CHEMI-PHARM andis osa oma varast üle omandavale ühingule Osaühingule Chemi-Pharm Group. Jagunemine kanti äriregistrisse 31.05.2023.
Kui jagunemisel osalevate ühingute võlausaldajad ei saa nõuda rahuldamist ja nad põhistavad, et jagunemine võib ohustada nende nõuete täitmist, siis on neil võimalus esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 447 lg 2¹) Ühingu ülaltoodud kontaktandmetel.
Osaühing Chemi-Pharm Group

Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 447 lg 21). Ruth@chemi-pharm.com

Ärinimed
Osaühing Chemi-Pharm Group, kehtetud ärinimed: osaühing Chemilex Group.
Osaühing Chemi-Pharm Group
Nõmme linnaosa, Tallinn, Harju maakond, Serva tn 44a
Telefon: +372 6778806
E-post: ruth@chemi-pharm.com
Teadaande number 2080505
Logo

Notice of preparation of division plan or conclusion of division agreement

13.04.2023
Jagunemiskava koostamise või jagunemislepingu sõlmimise teade
Avaldamise algus: 13.04.2023
Avaldamise lõpp: tähtajatu
Aktsiaselts CHEMI-PHARM (registrikood 10140819) avaldab teadaande äriseadustiku (ÄS) § 463 lõike 4 alusel.

Ühing teatab jagunemiskava koostamisest. Aktsiaselts CHEMI-PHARM (registrikood 10140819, aadress Tänassilma tee 11, Tänassilma küla, Saku vald, Harju maakond, e-posti aadress chemi-pharm@chemi-pharm.com), edaspidi nimetatud Aktsiaselts avaldab teadaande äriseadustiku (ÄS) § 463 lõike 4 alusel.
Aktsiaselts teatab jagunemislepingu sõlmimisest.

Jagunemisleping on sõlmitud Aktsiaseltsi ja Osaühing Chemi-Pharm Group (registrikood 10449072, aadress Serva tn 44a, Tallinn) vahel. Jagunemisleping sõlmiti 13.04.2023, selle alusel oli Aktsiaselts jagunev ühing ja Osaühing Chemi-Pharm Group oli omandav ühing. Vastavalt jagunemislepingule jaguneb Aktsiaselts eraldumise teel ning annab osa oma vara üle Osaühingule Chemi-Pharm Group.

Jagunemislepingu ja teiste dokumentidega on võimalik tutvuda ja saada nende ärakirju äriregistrist.

Aktsiaselts CHEMI-PHARM

Aktsiaselts CHEMI-PHARM
Tänassilma küla, Saku vald, Harju maakond, Tänassilma tee 11
Telefon: +372 6778806
E-post: chemi-pharm@chemi-pharm.com
Teadaande number 2061957

Marketing

Business network

CHEMI-PHARM AS

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

CHEMI-PHARM AS

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.

We value your privacy

We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.